Literature DB >> 28129685

A Safe and Effective Method for Wheat Oral Immunotherapy.

Alireza Khayatzadeh1, Mohamad Gharaghozlou1, Motohiro Ebisawa2, Raheleh Shokouhi Shoormasti3, Masoud Movahedi1.   

Abstract

At present the only available management for food allergy is avoidance; however, abstaining from allergic foods can affect the quality of life. Oral Immunotherapy (OIT) is an efficient method for increasing tolerance towards food allergens. The aim of this study was desensitizing patients above five years of age with wheat allergy and evaluating the safety and efficacy of OIT for children with IgE-mediated wheat allergy. The method of Rush Oral Immunotherapy (ROIT) was performed on 8 anaphylactic wheat allergic patients as well as outpatient method on 5 non-anaphylactic ones. In ROIT, build-up phase was performed during several days, but in outpatient, the amount of ingestion gradually increased to 5.2 g wheat protein within several weeks. After that, maintenance doses were prescribed daily for 3 months. Then, if the oral food challenge (OFC) was negative, the patients were considered to be in desensitized state, which meant they had to continue eating same doses without interruption. In ROIT, build-up phase continued for about 4.6 days during which, 21 from 71 doses, showed clinical symptoms (29.6%). On the contrary, outpatient method lasted approximately 72.4 days in which 356 doses were used and symptoms developed in only 9 doses (2.5%). In total -regardless of type of build-up phase- 12 patients could complete the maintenance phase with 1080 doses that 28 of them (2.6%) developed mild symptoms. Our OIT study proved to be safe and effective, although it is utterly evident that further investigation on more patients is necessary.

Entities:  

Keywords:  Food allergy; Food hypersensitivity; Food immunotherapy; Oral desensitization; Wheat; Wheat hypersensitivity

Mesh:

Substances:

Year:  2016        PMID: 28129685

Source DB:  PubMed          Journal:  Iran J Allergy Asthma Immunol        ISSN: 1735-1502            Impact factor:   1.464


  4 in total

1.  Evaluation of oral immunotherapy efficacy and safety by maintenance dose dependency: A multicenter randomized study.

Authors:  Kiyotake Ogura; Noriyuki Yanagida; Sakura Sato; Takanori Imai; Komei Ito; Naoyuki Kando; Masanori Ikeda; Rumiko Shibata; Yoko Murakami; Takao Fujisawa; Mizuho Nagao; Norio Kawamoto; Naomi Kondo; Atsuo Urisu; Ikuya Tsuge; Yasuto Kondo; Kazuko Sugai; Osamu Uchida; Mitsuyoshi Urashima; Masami Taniguchi; Motohiro Ebisawa
Journal:  World Allergy Organ J       Date:  2020-09-29       Impact factor: 4.084

2.  Oral Immunotherapy With Partially Hydrolyzed Wheat-Based Cereals: A Pilot Study.

Authors:  Roger Lauener; Philippe A Eigenmann; Jacqueline Wassenberg; Andreas Jung; Sandra Denery-Papini; Sigrid Sjölander; Sophie Pecquet; Rodolphe Fritsché; Adrian Zuercher; Antoine Wermeille; Massimo Fontanesi; Annick Mercenier; Yvonne M Vissers; Sophie Nutten
Journal:  Clin Med Insights Pediatr       Date:  2017-09-08

Review 3.  Oral Immunotherapy (OIT): A Personalized Medicine.

Authors:  Francesca Mori; Simona Barni; Giulia Liccioli; Elio Novembre
Journal:  Medicina (Kaunas)       Date:  2019-10-13       Impact factor: 2.430

4.  Feasibility of a 3-step protocol of wheat oral immunotherapy in children with severe wheat allergy.

Authors:  Chulamanee Wongteerayanee; Pattara Tanticharoenwiwat; Nuntanut Rutrakool; Anchalee Senavonge; Nivat Jeekungwal; Punchama Pacharn; Pakit Vichyanond
Journal:  Asia Pac Allergy       Date:  2020-10-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.